Market Research carried out in two cities of Gujarat- Ahmedabad and Rajkot- which gave an insight about the availability of newly launched products in medical stores. It also contains area wise availablity and leading brands.
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
To study the availability of new launched products of Zydus cadila
1. MARKET RESEARCH CONDUCTED ON
NEW LAUNCHED PRODUCTS OF
ZYDUS CADILA
Project Manager: Mrs. Babita Goyal
(Strategic Marketing Cell)
Survey conducted, analysed and presented by
Jay Nirmal
2. INTRODUCTION
Indian pharmaceutical market reached US$ 21.72
billion ( as of June 2011).
It is growing at the rate of 8-9% annually.
Thousands of new products are launched each
year.
Zydus Cadila has come up with many new products
in recent past.
4. RESEARCH METHODOLOGY
Type of Research Design:
Descriptive research
Sample Design:
Probability sampling
Stratified Random sampling
Sampling Frame:
Medical store
Sample Size:
175
Data Collection:
Primary data is collected through Schedules
6. Selling
Total selling of
Lacosamide molecule=
2795 Tablets
Total selling of Lacasa=
0
% selling= 0%
Selling
Total selling of
Lacosamide molecule=
Not found
Total selling of Lacasa=
Not found
% selling= --
AHMEDABAD RAJKOT
LACOSAMIDE
SODIUM
VALPROATE
TELMISARTAN METOPROLOL ROSUVASTATIN
7. Availability
No. of medical stores
having Lacosamide
molecule = 13
No. of medical stores
having Lacasa brand= 0
% availability= 0%
Availability
No. of medical stores
having Lacosamide
molecule = 4
No. of medical stores
having Lacasa brand= 1
% availability= 25%
AHMEDABAD RAJKOT
LACOSAMIDE
SODIUM
VALPROATE
TELMISARTAN METOPROLOL ROSUVASTATIN
8. Known
No. of medical stores not
having Lacasa= 13
No. of medical store that
did not knew about this
brand= 12
% unknown= 92.30%
Known
No. of medical stores not
having Lacasa= 3
No. of medical store that
did not knew about this
brand= 3
% unknown= 100%
AHMEDABAD RAJKOT
LACOSAMIDE
SODIUM
VALPROATE
TELMISARTAN METOPROLOL ROSUVASTATIN
10. Selling
Total selling of Sodium
Valproate molecule=
43240 Tablets
Total selling of Epima
Chrono= 55
% selling= 0.13%
Selling
Total selling of Sodium
Valproate molecule=
15750 Tablets
Total selling of Epima
Chrono= 1050
%selling= 6.67%
AHMEDABAD RAJKOT
LACOSAMIDE
SODIUM
VALPROATE
TELMISARTAN METOPROLOL ROSUVASTATIN
11. Availability
No. of medical stores
having Sodium Valproate
molecule = 94
No. of medical stores
having EpimaChrono
brand= 8
% availability= 8.51%
Availability
No. of medical stores
having Sodium Valproate
molecule = 68
No. of medical stores
having EpimaChrono
brand= 10
% availability= 14.71%
AHMEDABAD RAJKOT
LACOSAMIDE
SODIUM
VALPROATE
TELMISARTAN METOPROLOL ROSUVASTATIN
12. Known
No. of medical stores not
having Epima Chrono=
86
No. of medical store that
did not knew about this
brand= 68
% unknown= 79.07%
Known
No. of medical stores not
having Epima Chrono=
58
No. of medical store that
did not knew about this
brand= 42
% unknown= 72.41%
AHMEDABAD RAJKOT
LACOSAMIDE
SODIUM
VALPROATE
TELMISARTAN METOPROLOL ROSUVASTATIN
14. Selling
Total selling of Telmisartan
molecule= 33890 tabs
Total selling of Inditel= 2900 tabs
Total selling of Inditel AM= 2340
tabs
Combined selling= 5240 tabs
% selling= 15.46%
Selling
Total selling of Telmisartan
molecule= 18000 tabs
Total selling of Inditel= 3075 tabs
Total selling of Inditel AM= 1790
tabs
Combined selling= 4865 tabs
% selling= 27.03%
AHMEDABAD RAJKOT
LACOSAMIDE
SODIUM
VALPROATE
TELMISARTAN METOPROLOL ROSUVASTATIN
15. Availability
No. of medical stores having
Telmisartan molecule = 97
No. of medical stores having
Inditel brand= 60
% availability= 70.27%
No. of medical stores having
Inditel AM brand= 58
% availability= 61.85%
Availability
No. of medical stores having
Telmisartan molecule = 67
No. of medical stores having
Inditel brand= 38
% availability= 72.41%
No. of medical stores having
Inditel AM brand= 32
% availability= 60%
AHMEDABAD RAJKOT
LACOSAMIDE
SODIUM
VALPROATE
TELMISARTAN METOPROLOL ROSUVASTATIN
16. Known
No. of medical stores not
having Inditel= 37
No. of medical store that
did not knew about this
brand= 26
% unknown= 70.27%
Known
No. of medical stores
not having Inditel= 29
No. of medical store
that did not knew about
this brand= 21
% unknown= 72.41%
AHMEDABAD RAJKOT
LACOSAMIDE
SODIUM
VALPROATE
TELMISARTAN METOPROLOL ROSUVASTATIN
17. Combination
Combina
tion sold
(Out of
97)
-H -AM
No. of
medical
stores
69 57
% of
medical
stores
71.13 58.76
AHMEDABAD RAJKOT
Combination
Combi
nation
sold
(Out
of 67)
-H -AM
Other
s
No. of
medic
al
stores
19 8 3
% of
medic
al
stores
28.36 11.94 4.48
LACOSAMIDE
SODIUM
VALPROATE
TELMISARTAN METOPROLOL ROSUVASTATIN
19. Selling
Total selling of Metoprolol
molecule= 44665 tabs
Total selling of Sustamet= 1335
tabs
Total selling of Sustamet AM=
845 tabs
Combined selling= 2180 tabs
% selling= 4.88%
Selling
Total selling of Metoprolol
molecule= 13525 tabs
Total selling of Sustamet= 810
tabs
Total selling of Sustamet AM= 30
tabs
Combined selling= 840 tabs
% selling= 6.21%
AHMEDABAD RAJKOT
LACOSAMIDE
SODIUM
VALPROATE
TELMISARTAN METOPROLOL ROSUVASTATIN
20. Availability
No. of medical stores having
Metoprolol molecule = 92
No. of medical stores having
Sustamet brand= 34
% availability= 36.96%
No. of medical stores having
Sustamet AM brand= 29
% availability= 31.53%
Availability
No. of medical stores having
Metoprolol molecule = 68
No. of medical stores having
Sustamet brand= 12
% availability= %
No. of medical stores having
Sustamet AM brand= 9
% availability= 66.67%
AHMEDABAD RAJKOT
LACOSAMIDE
SODIUM
VALPROATE
TELMISARTAN METOPROLOL ROSUVASTATIN
21. Known
No. of medical stores not
having Sustamet= 58
No. of medical store that
did not knew about this
brand= 44
% unknown= 75.86%
Known
No. of medical stores not
having Sustamet= 56
No. of medical store that
did not knew about this
brand= 35
% unknown= 62.5%
AHMEDABAD RAJKOT
LACOSAMIDE
SODIUM
VALPROATE
TELMISARTAN METOPROLOL ROSUVASTATIN
22. Combination sold Combination sold
AHMEDABAD RAJKOT
Combination
sold (Out of
92)
-AM
No. of medical
stores
40
% of medical
stores
43.48
Combination
sold (Out of
68)
-AM
No. of medical
stores
3
% of medical
stores
4.11
LACOSAMIDE
SODIUM
VALPROATE
TELMISARTAN METOPROLOL ROSUVASTATIN
24. Selling
Total selling of Rosuvastatin
molecule= 25325 tabs
Total selling of Zyrova= 490 tabs
Total selling of Zyrova F= 25 tabs
Combined selling= 515 tabs
% selling= 2.03%
Selling
Total selling of Rosuvastatin
molecule= 13525 tabs
Total selling of Zyrova= 810 tabs
Total selling of Zyrova F= 30 tabs
Combined selling= 840 tabs
% selling= 6.21%
AHMEDABAD RAJKOT
LACOSAMIDE
SODIUM
VALPROATE
TELMISARTAN METOPROLOL
ROSUVA-
STATIN
25. Availability
No. of medical stores having
Rosuvastatin molecule = 90
No. of medical stores having
Zyrova brand= 15
% availability= 16.67%
No. of medical stores having
Zyrova F brand= 10
% availability= 11.11%
Availability
No. of medical stores having
Rosuvastatin molecule = 90
No. of medical stores having
Zyrova brand= 15
% availability= 29.41%
No. of medical stores having
Zyrova F brand= 7
% availability= 13.72%
AHMEDABAD RAJKOT
LACOSAMIDE
SODIUM
VALPROATE
TELMISARTAN METOPROLOL
ROSUVA-
STATIN
26. Known
No. of medical stores not
having Zyrova= 75
No. of medical store that
did not knew about this
brand= 59
% unknown= 78.66%
Known
No. of medical stores
not having Zyrova= 36
No. of medical store
that did not knew about
this brand= 32
% unknown= 88.89%
AHMEDABAD RAJKOT
LACOSAMIDE
SODIUM
VALPROATE
TELMISARTAN METOPROLOL
ROSUVA-
STATIN
27. Combination sold Combination sold
AHMEDABAD RAJKOT
Combination
sold (Out of
90)
-F
No. of medical
stores
30
% of medical
stores
33.33
Combination
sold (Out of
51)
-F
No. of medical
stores
2
% of medical
stores
3.92
LACOSAMIDE
SODIUM
VALPROATE
TELMISARTAN METOPROLOL
ROSUVA-
STATIN
29. FACTOR AFFECTING AVAILABILITY OF DRUGS
IN MEDICAL STORES
Preference of Doctor
Visits of MR
Affiliated to Physicians/ Hospitals
Central Location
30. AHMEDABAD
For Zydus Cadila
Preference of Doctor Doctors don’t prescribe much
Stockist availability Available
Pricing
Almost parallel, Not a matter of concern as
long as doctors prescribe
Schemes
Only if purchased in bulk, Not a matter of
concern as long as doctors prescribe
Side effect/ Drug interaction Not aware
Visits of MR
Not regular, in large medical stores and
stores affiliated to hospitals
31. RAJKOT
For Zydus Cadila
Preference of Doctor Doctors don’t prescribe much
Stockist availability Available
Pricing
Almost parallel, Not a matter of concern as
long as doctors prescribe
Schemes Only if purchased in bulk
Side effect/ Drug interaction Unaware, Not a factor
Visits of MR
Not regular, in large stores, no push for
some brands
32. FEEDBACK FROM MEDICAL STORE OWNERS
Better brands available in market
Running and set brands already available, no space
for new products
Infrequent or less visits of MR even though a
particular brand sells or is at least kept in the
medical store
MRs not much interested in selling
Push for brands in major medical stores only, in
major locations
Brands still not popular, most medical owners
haven't even heard the names
Little trust on Zydus Cadila products
33. SUGGESTIONS FOR AVAILABILITY IN
AHMEDABAD
Lacasa
Reaching out to particular hospitals and MR visits to
medical stores affiliated with these hospitals can help
enhance availability
Epima Chrono
Explaining Doctors for its pharmacological superiority
can help
Inditel
Utility branding for this molecule
Marketing Hydrothiazide combination may enhance the
sell.
34. Sustamet
Marketing the molecule to major physicians and
smaller hospitals and then gradually to larger
hospitals.
Zyrova
More MR interaction with the Medical store owners
and regular visit to Doctors can help.
35. SUGGESTIONS FOR AVAILABILITY IN RAJKOT
Lacasa
Not much market deveolped for Lacosamide, an early
call for its marketing may help capture the pie.
Epima Chrono
Explaining Doctors for its pharmacological superiority
can help.
Inditel
Utility branding for this molecule
Marketing Hydrothiazide combination may enhance the
sell.
36. Sustamet
More MR interaction with the Medical store owners
and regular visit to Doctors can help.
Zyrova
More MR interaction with the Medical store owners
and regular visit to Doctors can help.
37. CONCLUSION
As seen from the survey conducted, availability of
drugs are heavily dependent on prescription of
doctors, MR follow ups and to what extent the
brands are known by medical store owners.
Working on these three factors will help in
achieving the objective.